Lupus flare prevention drug trial halted early
Disease control
Terminated
This study tested a drug called PRV-3279 to see if it could prevent lupus flares in people with active systemic lupus erythematosus (SLE). Participants had moderate to severe disease and were first treated with steroids to calm their symptoms. The trial was stopped early and incl…
Phase: PHASE2 • Sponsor: Provention Bio, a Sanofi Company • Aim: Disease control
Last updated Jun 02, 2026 11:39 UTC